Market Analysis and Insights: Global Over the Counter OTC Drugs & Dietary Supplements Market
The global Over the Counter OTC Drugs & Dietary Supplements market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Over the Counter OTC Drugs & Dietary Supplements market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Over the Counter OTC Drugs & Dietary Supplements market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Over the Counter OTC Drugs & Dietary Supplements market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Over the Counter OTC Drugs & Dietary Supplements market.
Global Over the Counter OTC Drugs & Dietary Supplements Scope and Market Size
Over the Counter (OTC) Drugs & Dietary Supplements market is segmented
by players, region (country),
by Type and
by Application. Players, stakeholders, and other participants in the global Over the Counter (OTC) Drugs & Dietary Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast
by Type and
by Application for the period 2018-2029.
Segment by Type
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold, and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Over the Counter OTC Drugs & Dietary Supplements product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Over the Counter OTC Drugs & Dietary Supplements, with price, sales, revenue, and global market share of Over the Counter OTC Drugs & Dietary Supplements from 2019 to 2022.
Chapter 3, the Over the Counter OTC Drugs & Dietary Supplements competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Over the Counter OTC Drugs & Dietary Supplements breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Over the Counter OTC Drugs & Dietary Supplements market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Over the Counter OTC Drugs & Dietary Supplements.
Chapter 13, 14, and 15, to describe Over the Counter OTC Drugs & Dietary Supplements sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Over the Counter OTC Drugs & Dietary Supplements Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Analgesic & Pain Relievers
1.2.3 Dermatological Products
1.2.4 Cough, Cold, and Flu Products
1.2.5 Vitamin Supplements
1.2.6 Mineral Supplements
1.2.7 Ophthalmic Products
1.3 Market by Application
1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2018-2029)
2.2 Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region
2.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Region (2018-2023)
2.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2024-2029)
2.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
2.3.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
2.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
2.3.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
2.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue
3.1.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2018-2023)
3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2018-2023)
3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Over the Counter (OTC) Drugs & Dietary Supplements Revenue
3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio
3.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2022
3.5 Over the Counter (OTC) Drugs & Dietary Supplements Key Players Head office and Area Served
3.6 Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service
3.7 Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Type (2018-2023)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2024-2029)
5 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Application (2018-2023)
5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2029)
6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023)
6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2029)
7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023)
7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2029)
8.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023)
8.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2029)
9.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023)
9.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2029)
10.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023)
10.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.1.5 Pfizer Inc. Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Company Detail
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.2.5 Novartis International AG Recent Development
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Detail
11.3.2 Roche Holding AG Business Overview
11.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.3.5 Roche Holding AG Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Detail
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Sanofi S.A
11.5.1 Sanofi S.A Company Detail
11.5.2 Sanofi S.A Business Overview
11.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.5.5 Sanofi S.A Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Detail
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.7.5 Gilead Sciences Recent Development
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Company Detail
11.8.2 GlaxoSmithKline plc. Business Overview
11.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.8.5 GlaxoSmithKline plc. Recent Development
11.9 Bayer Healthcare AG
11.9.1 Bayer Healthcare AG Company Detail
11.9.2 Bayer Healthcare AG Business Overview
11.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.9.5 Bayer Healthcare AG Recent Development
11.10 AstraZeneca plc.
11.10.1 AstraZeneca plc. Company Detail
11.10.2 AstraZeneca plc. Business Overview
11.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.10.5 AstraZeneca plc. Recent Development
11.11 Alacer Corp.
11.11.1 Alacer Corp. Company Detail
11.11.2 Alacer Corp. Business Overview
11.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.11.5 Alacer Corp. Recent Development
11.12 Alcon Inc.
11.12.1 Alcon Inc. Company Detail
11.12.2 Alcon Inc. Business Overview
11.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.12.5 Alcon Inc. Recent Development
11.13 Alfresa Pharma Corporation
11.13.1 Alfresa Pharma Corporation Company Detail
11.13.2 Alfresa Pharma Corporation Business Overview
11.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.13.5 Alfresa Pharma Corporation Recent Development
11.14 Alkalon A/S
11.14.1 Alkalon A/S Company Detail
11.14.2 Alkalon A/S Business Overview
11.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.14.5 Alkalon A/S Recent Development
11.15 Alliance Healthcare
11.15.1 Alliance Healthcare Company Detail
11.15.2 Alliance Healthcare Business Overview
11.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.15.5 Alliance Healthcare Recent Development
11.16 Allergan, Plc.
11.16.1 Allergan, Plc. Company Detail
11.16.2 Allergan, Plc. Business Overview
11.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.16.5 Allergan, Plc. Recent Development
11.17 Reckitt Benckiser Plc.
11.17.1 Reckitt Benckiser Plc. Company Detail
11.17.2 Reckitt Benckiser Plc. Business Overview
11.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.17.5 Reckitt Benckiser Plc. Recent Development
11.18 Bausch & Lomb
11.18.1 Bausch & Lomb Company Detail
11.18.2 Bausch & Lomb Business Overview
11.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.18.5 Bausch & Lomb Recent Development
11.19 AbbVie Inc.
11.19.1 AbbVie Inc. Company Detail
11.19.2 AbbVie Inc. Business Overview
11.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.19.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.19.5 AbbVie Inc. Recent Development
11.20 The Colgate-Palmolive Company
11.20.1 The Colgate-Palmolive Company Company Detail
11.20.2 The Colgate-Palmolive Company Business Overview
11.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.20.5 The Colgate-Palmolive Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Analgesic & Pain Relievers
Table 3. Key Players of Dermatological Products
Table 4. Key Players of Cough, Cold, and Flu Products
Table 5. Key Players of Vitamin Supplements
Table 6. Key Players of Mineral Supplements
Table 7. Key Players of Ophthalmic Products
Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2018-2023)
Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2024-2029)
Table 14. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends
Table 15. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
Table 16. Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
Table 17. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players (2018-2023)
Table 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2022)
Table 21. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service
Table 25. Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2018-2023)
Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2024-2029)
Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2018-2023)
Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2024-2029)
Table 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2029) & (US$ Million)
Table 45. Pfizer Inc. Company Detail
Table 46. Pfizer Inc. Business Overview
Table 47. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 48. Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 49. Pfizer Inc. Recent Development
Table 50. Novartis International AG Company Detail
Table 51. Novartis International AG Business Overview
Table 52. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 53. Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 54. Novartis International AG Recent Development
Table 55. Roche Holding AG Company Detail
Table 56. Roche Holding AG Business Overview
Table 57. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 58. Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 59. Roche Holding AG Recent Development
Table 60. Merck & Co., Inc. Company Detail
Table 61. Merck & Co., Inc. Business Overview
Table 62. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 63. Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 64. Merck & Co., Inc. Recent Development
Table 65. Sanofi S.A Company Detail
Table 66. Sanofi S.A Business Overview
Table 67. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 68. Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 69. Sanofi S.A Recent Development
Table 70. Johnson & Johnson Company Detail
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 73. Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 74. Johnson & Johnson Recent Development
Table 75. Gilead Sciences Company Detail
Table 76. Gilead Sciences Business Overview
Table 77. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 78. Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 79. Gilead Sciences Recent Development
Table 80. GlaxoSmithKline plc. Company Detail
Table 81. GlaxoSmithKline plc. Business Overview
Table 82. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 83. GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 84. GlaxoSmithKline plc. Recent Development
Table 85. Bayer Healthcare AG Company Detail
Table 86. Bayer Healthcare AG Business Overview
Table 87. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 88. Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 89. Bayer Healthcare AG Recent Development
Table 90. AstraZeneca plc. Company Detail
Table 91. AstraZeneca plc. Business Overview
Table 92. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 93. AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 94. AstraZeneca plc. Recent Development
Table 95. Alacer Corp. Company Detail
Table 96. Alacer Corp. Business Overview
Table 97. Alacer Corp. Over the Counter (OTC) Drugs & Dietary SupplementsProduct
Table 98. Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 99. Alacer Corp. Recent Development
Table 100. Alcon Inc. Company Detail
Table 101. Alcon Inc. Business Overview
Table 102. Alcon Inc. Over the Counter (OTC) Drugs & Dietary SupplementsProduct
Table 103. Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 104. Alcon Inc. Recent Development
Table 105. Alfresa Pharma Corporation Company Detail
Table 106. Alfresa Pharma Corporation Business Overview
Table 107. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary SupplementsProduct
Table 108. Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 109. Alfresa Pharma Corporation Recent Development
Table 110. Alkalon A/S Company Detail
Table 111. Alkalon A/S Business Overview
Table 112. Alkalon A/S Over the Counter (OTC) Drugs & Dietary SupplementsProduct
Table 113. Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 114. Alkalon A/S Recent Development
Table 115. Alliance Healthcare Company Detail
Table 116. Alliance Healthcare Business Overview
Table 117. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary SupplementsProduct
Table 118. Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 119. Alliance Healthcare Recent Development
Table 120. Allergan, Plc. Company Detail
Table 121. Allergan, Plc. Business Overview
Table 122. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary SupplementsProduct
Table 123. Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 124. Allergan, Plc. Recent Development
Table 125. Reckitt Benckiser Plc. Company Detail
Table 126. Reckitt Benckiser Plc. Business Overview
Table 127. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary SupplementsProduct
Table 128. Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 129. Reckitt Benckiser Plc. Recent Development
Table 130. Bausch & Lomb Company Detail
Table 131. Bausch & Lomb Business Overview
Table 132. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary SupplementsProduct
Table 133. Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 134. Bausch & Lomb Recent Development
Table 135. AbbVie Inc. Company Detail
Table 136. AbbVie Inc. Business Overview
Table 137. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary SupplementsProduct
Table 138. AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 139. AbbVie Inc. Recent Development
Table 140. The Colgate-Palmolive Company Company Detail
Table 141. The Colgate-Palmolive Company Business Overview
Table 142. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary SupplementsProduct
Table 143. The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 144. The Colgate-Palmolive Company Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type: 2022 VS 2029
Figure 2. Analgesic & Pain Relievers Features
Figure 3. Dermatological Products Features
Figure 4. Cough, Cold, and Flu Products Features
Figure 5. Vitamin Supplements Features
Figure 6. Mineral Supplements Features
Figure 7. Ophthalmic Products Features
Figure 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2022 & 2029
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacy Case Studies
Figure 12. Others Case Studies
Figure 13. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered
Figure 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2022 VS 2029
Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players in 2022
Figure 18. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2022
Figure 20. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2029)
Figure 22. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2029)
Figure 26. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2018-2029)
Figure 34. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2029)
Figure 42. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2029)
Figure 46. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Pfizer Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 49. Novartis International AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 50. Roche Holding AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 51. Merck & Co., Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 52. Sanofi S.A Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 54. Gilead Sciences Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 55. GlaxoSmithKline plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 56. Bayer Healthcare AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 57. AstraZeneca plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 58. Alacer Corp. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 59. Alcon Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 60. Alfresa Pharma Corporation Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 61. Alkalon A/S Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 62. Alliance Healthcare Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 63. Allergan, Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 64. Reckitt Benckiser Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 65. Bausch & Lomb Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 66. AbbVie Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 67. The Colgate-Palmolive Company Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
